CCR8 antagonist 2 is a potent antagonist of CCR8. CCR8 (C-C Motif Chemokine Receptor 8) is predominantly expressed on Treg cells and Th2 cells, but not on Th1 cells. CCR8 antagonist 2 inhibits CCR8 activity, which may be used in the treatment of diseases mediated by CCR8, such as cancer, and/or neuropathic pain (extracted from patent WO2022000443A1, compound 220).
性状
Solid
IC50 & Target[1][2]
CCR8
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moisture and light In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
参考文献
[1]. Guohuang FAN, et al. Methods and compositions for targeting tregs using ccr8 inhibitors.
溶解度数据
In Vitro: DMSO : 4 mg/mL (8.62 mM; ultrasonic and warming and heat to 60°C)配制储备液